480mgMalaria

Altisplus

ALTIS PLUS

Lumefantrine

RAY PHARMA

Drug Identity

Active Ingredient
Lumefantrine
Drug Class
Antimalarials
0

How to Take It

Dosage information not available for this product.

Safety Alerts

History of arrhythmias, clinical relevant bradycardia, congestive heart failure accompanied by reduced ventricular ejection fraction
family history of sudden death or of congenital QT interval prolongation

Important Warnings

Electrolyte disturbances, concomitant use with other drugs known to cause QT-interval prolongation, monitor patients unable to take food (greater risk of recrudescence)
Dizziness may affect performance

Side Effects

Abdominal painataxiaanorexiaarthralgiaastheniacoughdiarrhoeamuscle weaknessdizzinessheadachemyalgianauseapalpitationparaesthesiaprolonged QT interval

Drug Interactions

Inhibitors of CYP3A4
substrates of CYP2D6
grapefruit juice
class la and III antiarrhythmics
drugs prolonging QT interval
fluoroquinolones
azole antifungals
cisapride.

Pregnancy & Lactation

Pregnancy
Avoid unless benefits outweigh risk
Lactation
Contraindicated

Price Intelligence

Rs 469.2
DRAP approved maximum price · per pack of 4 · approved 27 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 4Rs 469.2

Should you consider an alternative?

Other options containing Lumefantrine, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

66
brands
59
molecules
0
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.